Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ammonia Solution, Strong SCHEMBL28143707 | 1.00 | MEN1 (0.40) | MEN1KMT2A | |
| Ammonia Solution, Strong SCHEMBL19469337 | 0.96 | MEN1 (0.38) | MEN1KMT2A | |
| SCHEMBL5544690 | 0.96 | MEN1 (0.42) | MEN1KMT2A | |
| SCHEMBL7097725 | 0.96 | — | — | |
| SCHEMBL1746 | 0.96 | — | — | |
| Iodide SCHEMBL115029 | 0.92 | MEN1 (0.40) | MEN1KMT2A | |
| SCHEMBL3210291 | 0.92 | MEN1 (0.40) | MEN1KMT2A | |
| Hydrochloric Acid SCHEMBL22577541 | 0.92 | MEN1 (0.40) | MEN1KMT2A | |
| Fluoride SCHEMBL73855 | 0.92 | MEN1 (0.40) | MEN1KMT2A | |
| Fluoride SCHEMBL1025917 | 0.92 | MEN1 (0.40) | MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 187 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-105294426-B | Azetidinone compounds Preparation Method And Their Intermediate | 浙江海正药业股份有限公司 | 2019-05-14 | — | — | CN | claimed |
| CN-105294426-A | Preparation method for azacyclobutanone compound and intermediate of azacyclobutanone compound | ZHEJIANG HISUN PHARM CO LTD | 2016-02-03 | — | — | CN | claimed |
| CN-103506163-B | Quasi homogeneous magnetic nano-particle supported palladium catalyst and preparation method | UNIV NANJING SCIENCE & TECH | 2015-07-22 | — | — | CN | claimed |
| CN-103506163-A | Quasi homogeneous magnetic nano-particle supported palladium catalyst and preparation method | UNIV NANJING SCIENCE & TECH | 2014-01-15 | — | — | CN | claimed |
| CN-101575332-A | Diazacyclo propenyl-contained non-natural nucleoside, preparation method and applications thereof | BEIJING OKEANOS TECH CO LTD (CN) | 2009-11-11 | — | — | CN | claimed |
| CN-119113136-A | Application of RNAi agent in treating periodontitis and related diseases | 北京瑞博开拓医药科技有限公司 | 2024-12-13 | — | — | CN | disclosed |
| US-20240109915-A1 | NOVEL ACC INHIBITORS | PFIZER INC. (US) | 2024-04-04 | — | — | US | disclosed |
| CN-117813306-A | Heterocyclic compounds as KRAS inhibitors, their preparation and therapeutic use | 上海科州药物研发有限公司 | 2024-04-02 | — | — | CN | disclosed |
| US-20240083906-A1 | COMPOUNDS AND METHODS FOR INHIBITING MITOTIC PROGRESSION | MILLENNIUM PHARM INC (US) | 2024-03-14 | — | — | US | disclosed |
| CN-117659421-A | Zn-based organic coordination nano-particle, preparation method thereof, photoresist composition and application thereof | 清华大学 | 2024-03-08 | — | — | CN | disclosed |
| CN-117659055-A | Zn-based organic coordination nano-particle, preparation method thereof, photoresist composition containing Zn-based organic coordination nano-particle and application of Zn-based organic coordination nano-particle | 清华大学 | 2024-03-08 | — | — | CN | disclosed |
| WO-2024046108-A1 | ZN-BASED ORGANIC COORDINATION NANOPARTICLE AND PREPARATION METHOD THEREFOR, PHOTORESIST COMPOSITION CONTAINING SAME, AND USE THEREOF | 清华大学 | 2024-03-07 | — | — | WO | disclosed |
| US-20020161000-A1 | Pyridine matrix metalloproteinase inhibitors | WARNER-LAMBERT COMPANY | 2002-10-31 | — | — | US | disclosed |
| WO-2002064568-A1 | PYRIDINE MATRIX METALLOPROTEINASE INHIBITORS | WARNER-LAMBERT COMPANY LLC (US) | 2002-08-22 | — | — | WO | disclosed |
| CN-1353706-A | Integrin receptor ligands | BASF AG (DE) | 2002-06-12 | — | — | CN | disclosed |
| US-5602141-A | WATER SOLUBILITY; TREATMENT OF LEUKEMIA | PHARMACIA & UPJOHN S.P.A. (IT) | 1997-02-11 | — | — | US | disclosed |
| US-4028113-A | Photographic supports and elements utilizing photobleachable O-nitroarylidene dyes | EASTMAN KODAK COMPANY (US) | 1977-06-07 | — | — | US | disclosed |
| US-3988156-A | Photographic supports and elements utilizing photobleachable o-nitroarylidene dyes | EASTMAN KODAK COMPANY (US) | 1976-10-26 | — | — | US | disclosed |
| US-3988154-A | Photographic supports and elements utilizing photobleachable omicron-nitroarylidene dyes | EASTMAN KODAK COMPANY (US) | 1976-10-26 | — | — | US | disclosed |
| US-3984248-A | Photographic polymeric film supports containing photobleachable o-nitroarylidene dyes | EASTMAN KODAK COMPANY (US) | 1976-10-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240109915-A1 | NOVEL ACC INHIBITORS | CBR3, NAT1, ACACB | MEN1 4404/4885KMT2A 3997/4885 |
| US-20020161000-A1 | Pyridine matrix metalloproteinase inhibitors | MMP13, MMP3, MMP11 | MEN1 4337/4885KMT2A 1722/4885 |
| US-20240083906-A1 | COMPOUNDS AND METHODS FOR INHIBITING MITOTIC PROGRESSION | AURKC, AURKA, AURKB | MEN1 717/4885KMT2A 628/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.